We look forward to presenting our various exciting research efforts at the upcoming 2023 European Association of Nuclear Medicine (EANM) Annual Congress Meeting, Vienna, September 9-13:
(Abstracts can be found here).
Oral Presentations:
A. Fele-Paranj, C. Uribe, F. Benard, A. Rahmim, B. Saboury
Theranostic digital blueprint predicts higher therapeutic efficacy using radiopharmaceuticals with higher albumin affinity
C. Miller, X. Hou, J. Brosch-Lenz, A. Rahmim, C. Uribe
Image quantification and quality assessment of dual-isotope 99mTc and 177Lu SPECT for bone marrow dosimetry: a simulation study
A. Toosi, S. Harsini, H. Abdollahi, F. Bénard, C. F. Uribe, A. Rahmim
Exploring correlations between PSA levels and PSMA-PET images in recurrent prostate cancer using machine learning, tensor radiomics and deep features analysis
J. Brosch-Lenz, N. Colpo, I. Bloise, X. Hou, W. R. Parulekar, C. Dellar, F. Saad, K. Chi, D. Wilson, F. Bénard, A. Rahmim, C. Uribe
Can pre-therapy 68Ga-PSMA-11 PET SUVs predict absorbed doses across multiple cycles of 177Lu-PSMA-617 therapy of mCRPC patients?
S. Ahamed, C. Uribe, A. Rahmim
Estimating the tumor localization performance via class-activation map explanations of a slice classification neural network without pixel-Level supervision
L. Polson, R. Fedrigo, C. Uribe, A. Rahmim
Assessing the efficacy of the relative difference prior for SPECT dosimetry
K. Thielemans, A. L. Kesner, E. Asma, J. Cabello, M. J. Cook, M. Hansen, J. Jones, N. A. Karakatsanis, E. K. Leung, P. Markiewicz, S. Prevrhal, A. Rahmim, B. Saboury, J. Stairs, S. Stute, H. Tashima, G. Wells
An academic/industrial PET raw data standardisation initiative
R. Danieli, M. Stella, C. Marin, J. Tran Gia, J. Leube, C. Uribe-Munoz, M. Hesse, H. Levillain, B. Vanderlinden, N. Reynaert, P. Flamen
Quantitative 177Lu SPECT/CT imaging with a ring-shaped CZT-based camera: 208 vs 113 keV photopeak
Posters:
F. Yousefirizi, C. Gowdy, I. Klyuzhin, K. Savage, C. Uribe, A. Rahmim
Utility of delta radiomics for response evaluation in primary mediastinal large B-cell lymphoma
H. Abdollahi, X. Hou, J. Beauregard, C. Uribe, A. Rahmim
Radiomics analysis in 177Lu-DOTATATE therapy: Extracting new information from theranostic images
J. Brosch-Lenz, N. Colpo, I. Bloise, X. Hou1 , W. R. Parulekar, C. Dellar, F. Saad, K. Chi, D. Wilson, F. Bénard, A. Rahmim, C. Uribe Absorbed dose prediction for subsequent therapy cycles from 1st cycle of 177Lu-PSMA-617 therapy of mCRPC patients
R. Fedrigo, L. Polson, C. Li, S. Harsini, I. Bloise, J. Brosch-Lenz, B. Saboury, F. Bénard, A. Rahmim, C. Uribe
Semiautomatic segmentation for tumour dosimetry in PSMA radiopharmaceutical therapy using a novel digital twins framework
R. Fedrigo, J. Tran-Gia, J. Brosch-Lenz, P. Petric, L. Fougner, K. Sabo, R. Ralea, S. Harsini, I. Bloise, J.M. Beauregard, F. Bénard, A. Rahmim, C. Uribe
Implementation of an 18F PET / 177Lu SPECT Phantom Study for Personalized Theranostics in PSMA Radiopharmaceutical Therapies
N. Reshtebar, S. Hosseini, A. Rahmim, P. Sheikhzadeh
Quantitative analysis of dual time point in FDG PET/CT images
